{
  "id": 8884350,
  "title": "Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs",
  "url": "https://urgent.news/2026/09/21/novo-stock-falls-as-much-as-7-despite-23-billion-sales-target-for",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-21T08:47:41.000Z",
  "source": {
    "name": "CNBC World",
    "slug": "cnbc-world",
    "url": "https://www.cnbc.com/2026/09/21/novo-nordisk-stock-sales-target-obesity-drugs.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "CNBC",
        "title": "Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs",
        "url": "https://urgent.news/2026/09/21/novo-stock-falls-as-much-as-7-despite-23-billion-sales-target-for-8885225",
        "published": "2026-09-21T08:47:41.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}